Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.verified

VVOS

Price:

$5.1119

Market Cap:

$24.72M

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands R...[Read more]

Industry

Medical - Devices

IPO Date

2020-12-11

Stock Exchange

NASDAQ

Ticker

VVOS

The Enterprise Value as of December 2024 (TTM) for Vivos Therapeutics, Inc. (VVOS) is 20.05M

According to Vivos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.05M. This represents a change of 77.07% compared to the average of 11.32M of the last 4 quarters.

Vivos Therapeutics, Inc. (VVOS) Historical Enterprise Value (quarterly & annually)

How has VVOS Enterprise Value performed in the past?

The mean historical Enterprise Value of Vivos Therapeutics, Inc. over the last ten years is 59.63M. The current 20.05M Enterprise Value has changed 3.26% with respect to the historical average. Over the past ten years (40 quarters), VVOS's Enterprise Value was at its highest in in the December 2019 quarter at 114.97M. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

59.63M

Median

58.04M

Minimum

8.14M

Maximum

114.81M

Vivos Therapeutics, Inc. (VVOS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vivos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 90.56%

Maximum Annual Enterprise Value = 114.81M

Minimum Annual Increase = -72.02%

Minimum Annual Enterprise Value = 8.14M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202315.52M90.56%
20228.14M-67.90%
202125.38M-72.02%
202090.70M-21.00%
2019114.81M11.20%

Vivos Therapeutics, Inc. (VVOS) Average Enterprise Value

How has VVOS Enterprise Value performed in the past?

The current Enterprise Value of Vivos Therapeutics, Inc. (VVOS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

16.35M

5-year avg

50.91M

10-year avg

59.63M

Vivos Therapeutics, Inc. (VVOS) Enterprise Value vs. Peers

How is VVOS’s Enterprise Value compared to its peers?

Vivos Therapeutics, Inc.’s Enterprise Value is greater than Bone Biologics Corporation (-1278297.00), greater than Tivic Health Systems, Inc. (-331611.00), greater than Bluejay Diagnostics, Inc. (-3310966.00), less than Rapid Micro Biosystems, Inc. (23.14M), greater than NanoVibronix, Inc. (986.48K), greater than Talis Biomedical Corporation (-37931750.00), greater than Nuwellis, Inc. (3.20M), greater than Heart Test Laboratories, Inc. (-1145434848.00),

Build a custom stock screener for Vivos Therapeutics, Inc. (VVOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vivos Therapeutics, Inc. (VVOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vivos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Vivos Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Vivos Therapeutics, Inc. (VVOS)?

What is the 3-year average Enterprise Value for Vivos Therapeutics, Inc. (VVOS)?

What is the 5-year average Enterprise Value for Vivos Therapeutics, Inc. (VVOS)?

How does the current Enterprise Value for Vivos Therapeutics, Inc. (VVOS) compare to its historical average?